Sionna Therapeutics Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ null, 3, 3.33, 27.17, 81.41 ], "ebit_estimate": [ -129.89, -149.28, -179.04, -175.43, -164.2 ], "ebitda_estimate": [ -127.5, -156.96, -187.02, -101.28, null ], "net_income_estimate": [ -119.77, -141.79, -173.95, -174.42, -163.39 ], "per_share_eps_estimate": [ -2.6, -2.83, -3.24, -2.9, -2.59 ], "eps_nri_estimate": [ -2.6, -2.83, -3.23, -2.9, -2.59 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -120.61, -144.24, -180.36, -194.85, -185.39 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ -24, -34, -44, -92, null ], "roe_estimate": [ -25, -36, -48, -103, null ], "gross_margin_estimate": [ null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": -18.67, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": -18.81, "future_eps_nri_estimate_growth": -18.67, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -25.07, "future_ebitda_estimate_growth": -27.87, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -30.76, "future_pretax_income_estimate_growth": -32.32, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": -16.84, "future_roe_estimate_growth": -17.36, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ null, null, null, null, null, null, null, null ], "ebit_estimate": [ -31.09, -34.74, -35.76, -37.12, -31.38, -32.53, -33.68, null ], "ebitda_estimate": [ -28.8, -39.3, -37.05, -51.28, null, null, null, null ], "net_income_estimate": [ -29.22, -30.76, -32.39, -27.29, -28.5, -29.73, -30.97, null ], "per_share_eps_estimate": [ -0.65, -0.67, -0.69, -0.66, -0.58, -0.59, -0.62, null ], "eps_nri_estimate": [ -0.65, -0.67, -0.69, -0.66, -0.58, -0.59, -0.62, -0.82 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -28.63, -29.82, -31.24, -27.23, -28.5, -29.73, -30.97, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null, null ], "long_term_growth_rate_mean": -18.67, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": -18.81, "future_eps_nri_estimate_growth": -18.67, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -25.07, "future_ebitda_estimate_growth": -27.87, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -30.76, "future_pretax_income_estimate_growth": -32.32, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": -16.84, "future_roe_estimate_growth": -17.36, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }